肾脏累及的弥漫性大B细胞淋巴瘤患者临床病理特征
|
王博恩, 陈思远, 施晴, 张慕晨, 易红梅, 董磊, 王黎, 程澍, 许彭鹏, 赵维莅
|
Clinicopathologic characteristics of patients with kidney-involved diffuse large B-cell lymphoma
|
WANG Boen, CHEN Siyuan, SHI Qing, ZHANG Muchen, YI Hongmei, DONG Lei, WANG Li, CHENG Shu, XU Pengpeng, ZHAO Weili
|
|
表2 肾脏累及的DLBCL患者预后的单因素分析
|
Tab 2 Univariate analysis in patients with kidney-involved DLBCL
|
|
Characteristic | OS | | PFS |
---|
HR (95%CI) | P value | | HR (95%CI) | P value |
---|
Age (>60 years) | 1.514 (0.914‒2.508) | 0.108 | | 1.359 (0.821‒2.251) | 0.233 | ECOG score (≥2 score) | 1.675 (0.939‒2.986) | 0.081 | | 1.487 (0.809‒2.733) | 0.202 | Ann Arbor (Ⅲ‒Ⅳ) | 1.119 (0.607‒2.060) | 0.719 | | 1.257 (0.657‒2.046) | 0.489 | Elevated serum LDH | 2.045 (1.018‒4.151) | 0.048 | | 2.241 (1.067‒4.704) | 0.033 | Extranodal involvement≥2 | 1.069 (0.621‒1.843) | 0.809 | | 1.600 (0.871‒2.941) | 0.130 | Hans (non-GCB) | 1.577 (0.969‒2.568) | 0.067 | | 1.361 (0.834‒2.220) | 0.217 | MYC and BCL2 double expressor | 1.210 (0.574‒2.552) | 0.616 | | 1.073 (0.543‒2.121) | 0.839 |
|
|
|